The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot-specific quality issue.Based on available information, the reported slda was due to patient anatomy.The reported recurrent mr was a cascading event of the reported slda.The reported dyspnea was a cascading event of the reported recurrent mr.The reported patient effects of mitral regurgitation and dyspnea, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The reported hospitalization and unexpected medical intervention were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|
It was reported that on 10november2024, a mitraclip procedure was performed to treat functional mitral regurgitation (mr) with a grade of 3+, a rotated heart, and thick leaflets.One clip was implanted, reducing mr to a grade of 1.On 01january2024, the patient returned to the hospital with shortness of breath and imaging showed the implanted clip had detached from the posterior leaflet and remained attached to the anterior leaflet (single leaflet device attachement/slda), causing mr to increase to a grade of 3.On 01march2024, an additional mitraclip was performed, and one clip with implanted, reducing mr to a grade of <1.
|